tirzepatide caremark CVS is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE In 2025, CVS Caremark excluded

References Budisak, P., Patel, P., & Abbas, M

15 mg-2: -1.8% [0.19])

More serious but less common adverse effects observed across the incretin drug class and under investigation for retatrutide include: Pancreatitis : Seek urgent medical attention if you experience severe, persistent abdominal pain, particularly if it radiates to the back

The medication may already be less effectiveeven if there are no visible signs

Rapid improvements in blood glucose levels can temporarily worsen diabetic retinopathy in some individuals

Although relationships with unobserved variables cannot be tested, we assessed characteristics of patients with vs without any follow-up weight